JAKARTA - The number of COVID-19 positive patients in the cluster of AD Officer Candidate School (Secapa) students in Bandung continues to decrease after the second swab test. Today, there are 201 more patients who have recovered or tested negative for COVID-19.
"PCR (polymerase chain reaction) lab results from the continued swab at Secapa AD until Saturday, July 25, there were 201 patients who had recovered," said Head of the Army Information Service, Brigadier General TNI Nefra Firdaus in an official statement, Jakarta, Saturday, July 25.
Thus, he said, out of a total of 1,308 positive COVID-19 patients, 819 people had decreased. "Or 62.6 percent have recovered, leaving 489 people or 37.4 percent still positive," he said.
He continued, of the 489 positive patients, 10 were still being treated at the Dustira Army Hospital, Bandung. Meanwhile, 479 patients were still in isolation. "Being in Secapa AD (isolation) without any complaints," he said.
The Chief of Staff of the Indonesian Army, General Andika Perkasa, previously said that in supporting the handling of COVID-19, his party was collaborating on research conducted by Unair Hospital regarding the COVID-19 drug.
On Thursday last week, the second PCR laboratory began to operate, namely at the Sariningsih Army Hospital, Bandung, to accelerate the service of examining specimens from swab test results in Bandung and its surroundings, after operating the PCR laboratory at Gatot Soebroto Army Hospital.
This operation is part of the procurement of 68 PCR laboratories for 68 TNI AD hospitals throughout Indonesia, as support for the Task Force for the Acceleration of Handling COVID-19.
All efforts have been made by the Indonesian Army, both in the procurement of medical equipment for medical personnel to collaborating with other hospitals, in order to reduce the current spread of the COVID-19 virus in undergoing a new normal era.
In addition, Adnika has also asked the Head of the Army Health Center (Kapuskes AD) Brigadier General Asrofi Sueb Surachman to accelerate the coordination of the implementation of the clinical trial of the COVID-19 drug combination with all Heads of the Indonesian Army Hospital.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
